国际药物开发与研究杂志

  • 国际标准期刊号: 0975-9344
  • 期刊 h 指数: 44
  • 期刊引用分数: 59.93
  • 期刊影响因子: 48.80
索引于
  • Genamics 期刊搜索
  • 中国知网(CNKI)
  • 引用因子
  • 西马戈
  • 研究期刊索引目录 (DRJI)
  • OCLC-WorldCat
  • 普布隆斯
  • 米亚尔
  • 大学教育资助委员会
  • 欧洲酒吧
  • 谷歌学术
  • 夏尔巴罗密欧
  • 秘密搜索引擎实验室
  • 研究之门
分享此页面

抽象的

Combination of Natural Agent with Synthetic Drug for the Breast Cancer Therapy

Bharti Mangla and Kanchan Kohli

Introduction: Breast cancer is the major cause of death worldwide. Urgently treatment is needed. A number of undesired side effects sometimes occur during the conventional therapy of cancer. Bioactive compounds derived from plant are the most popular alternative medicine which may reduce adverse effects. Various herbal compounds have been identified and showed very promising anti-cancer properties.

Methodology: The review was systematically conducted by searching the databases of MEDLINE, PubMed, Web of Knowledge, Google Scholar and Science Direct for original research articles and books using relevant search terms.

Results: The potential of combining phytomedicine or natural products with synthetic drugs or introducing these into conventional treatment regimens are not yet systematically explored. Combinatorial strategy may hold promise in development of therapies and chemoprevention strategies against ER-positive breast tumors.

Discussion: The screening for synergetic effects of such combinations is technically demanding and complex, also in the context of drug/herb interactions, but likely to substantially advance pharmacotherapy and future medicine.

Conclusion: It has been concluded that combined effect may improve the treatment effectiveness in combating proliferation of cancer cells, enhancing therapeutic efficacy, as well as abrogating drug resistance.

免责声明: 此摘要通过人工智能工具翻译,尚未经过审核或验证